Label: ARIELLA HEMORRHOID- lidocaine, phenylephrine hcl ointment

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 4, 2024

If you are a consumer or patient please visit this version.

  • PRINCIPAL DISPLAY PANEL

    Drug Facts

    20241029-204048

    Active ingredients Purpose

    Lidocaine 6% ………………………….………………………………………………………...….Protectant

    Phenylephrine HCL 0.25%…………………………………………….……………………..Vasoconstrictor

    Lidocaine 6% ………………………….………………………………………………………...….Protectant

    Phenylephrine HCL 0.25%…………………………………………….……………………..Vasoconstrictor

    Uses

    -helps relieve itching and discomfort associated with hemorrhoids - temporarily shrinks swelling and relieves burning and pain -soothes and protects irritated tissue

    For external and/or intrarectal use only

    Ask a doctor before use if you have

    -heart disease -high blood pressure - thyroid disease - diabetes -difficulty in urination due to enlargement of the prostate gland

    Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression.

    When using this product do not exceed the recommended daily dosage unless directed by a doctor

    Stop and ask a doctor if - bleeding occurs -condition worsens or does not improve within 7 days -introduction of the applicator into the rectum causes additional pain -an allergic reaction occurs - symptom does not improve or if redness, irritation, swelling, pain or other symptoms develop or increase

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away. (1-800-222-1222)

    Warnings

    Directions

    -when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before application.

    -apply half the gel in the applicator to the external affected area (only applies if you have external symptoms)

    -find a comfortable position and gently insert about ½ inch into the rectum.

    -push the end of the applicator to apply the remaining gel inside the rectum (Both steps are necessary for both internal and external symptoms as external hemorrhoid often comes with internal hemorrhoid)

    -dispose the applicator after use.

    -avoid movement for 1-3 hours

    -Children under 12 years of age: ask a doctor

    Other information store at 15-25°C (59-77°F)

    Inactive ingredients Borneol, Carbomer Homopolymer, Chlorhexidine Acetate, Glycerin, Thymol

  • INGREDIENTS AND APPEARANCE
    ARIELLA HEMORRHOID 
    lidocaine, phenylephrine hcl ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83364-012(NDC:84010-001)
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE0.25 g  in 100 g
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    BORNEOL (UNII: M89NIB437X)  
    CHLORHEXIDINE ACETATE (UNII: 5908ZUF22Y)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    THYMOL (UNII: 3J50XA376E)  
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83364-012-016 in 1 BOX11/01/2024
    13 g in 1 APPLICATOR; Type 0: Not a Combination Product
    2NDC:83364-012-0212 in 1 BOX11/01/2024
    23 g in 1 APPLICATOR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01611/01/2024
    Labeler - YITONGBADA (SHENZHEN) INTERNATIONAL TRADE CO., LTD (725220463)